Pharmakonzern · Frankreich
Sanofi
Ein Konzern aus 185 Unternehmen: 2.965 Arzneimittel, verteilt auf 13 Länder.
Konzernstruktur
185 Unternehmen, verteilt auf 25 Länder
Wird geladen …
Pharmakonzern · Frankreich
Ein Konzern aus 185 Unternehmen: 2.965 Arzneimittel, verteilt auf 13 Länder.
185 Unternehmen, verteilt auf 25 Länder
Ein kostenloses Konto für die Prognia-Apps: Ward zum Lernen, Osler für klinische Antworten mit ihren Quellen und das Netzwerk, um deine Kolleginnen und Kollegen zu finden.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Alle Arzneimittel aller Unternehmen im Konzern, aktuelle zuerst.
1–25 von 2.965
| Arzneimittel | Wirkstoff | Land | Status | Zulassung |
|---|---|---|---|---|
| ACCURBRON150mg/15ml · Syrup | Theophylline | Vereinigte Staaten | Nicht im Handel | |
| ACICLOVIR | Aciclovir | Brasilien | Zugelassen | 2015 |
| Acido Mefenamico | Mefenamic acid | Brasilien | Zugelassen | 2015 |
| ACOVIL 10 MG COMPRIMIDOS10 mg · Comprimido | Ramipril | Spanien | Im Handel | 2025 |
| ACOVIL 10 mg COMPRIMIDOS10 mg · Comprimido | Ramipril | Spanien | Im Handel | 2024 |
| ACOVIL 10 mg COMPRIMIDOS10 mg · Comprimido | Ramipril | Spanien | Im Handel | 2020 |
| ACOVIL 10 mg COMPRIMIDOS10 mg · Comprimido | Ramipril | Spanien | Im Handel | 2002 |
| ACOVIL 10 MG COMPRIMIDOS10 mg · Comprimido | Ramipril | Spanien | Im Handel | 2021 |
| ACOVIL 2,5 mg COMPRIMIDOS2,5 mg · Comprimido | Ramipril | Spanien | Im Handel | 1992 |
| ACOVIL 5 mg COMPRIMIDOS5 mg · Comprimido | Ramipril | Spanien | Im Handel | 2024 |
| ACOVIL 5 mg COMPRIMIDOS5 mg · Comprimido | Ramipril | Spanien | Im Handel | 1992 |
| ACOVIL 5 MG COMPRIMIDOS5 mg · Comprimido | Ramipril | Spanien | Im Handel | 2025 |
| ACOVIL 5 mg COMPRIMIDOS5 ip · Comprimido | Ramipril | Spanien | Im Handel | 2020 |
| ACT-HIB10 mcg / 0.5 ml + 30 mcg / 0.5 ml · Kit, Powder For Solution | Haemophilus influenzae type b-prp, Tetanus protein | Kanada | Im Handel | 1992 |
| Act-Hib, 10 microgram/0,5 ml poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Haemophilus influenzae type b polysaccharide geconjugeerd aan tetanus toxoïd | Niederlande | Zugelassen | 1993 |
| ACTHAR25 units/vial | 40 units/vial · Injectable | Corticotropin | Vereinigte Staaten | Nicht im Handel | 1950 |
| Acthib,Omnihib24ug · For Injection | Haemophilus b conjugate vaccine | Vereinigte Staaten | Im Handel | 2000 |
| ADACEL | Pertussis toxoid, Hemaglutinina filamentosa, Toxóide diftérico, Aglutinógenos fimbriais bordetella pertussis dos sorotipos e, Toxóide tetânico, Pertactin | Brasilien | Zugelassen | 2019 |
| Adacel0.5ml · Injection | Tetanus toxoid, reduced diphtheria toxoid, Acellular pertussis vaccine, adsorbed | Vereinigte Staaten | Im Handel | 2005 |
| ADACEL2 lf / 0.5 ml + 5 mcg / 0.5 ml + 5 mcg / 0.5 ml + 3 mcg / 0.5 ml + 2.5 mcg / 0.5 ml + 5 lf / 0.5 ml · Suspension | Diphtheria toxoid, Filamentous haemagglutinin, Fimbriae types and, Pertactin, Pertussis toxoid, Tetanus toxoid | Kanada | Im Handel | 1999 |
| ADACEL-POLIO2 lf / 0.5 ml + 5 mcg / 0.5 ml + 5 mcg / 0.5 ml + 3 mcg / 0.5 ml + 2.5 mcg / 0.5 ml + 29 unit / 0.5 ml + 7 unit / 0.5 ml + 26 unit / 0.5 ml + 5 lf / 0.5 ml · Suspension | Diphtheria toxoid, Filamentous haemagglutinin, Fimbriae types and, Pertactin, Pertussis toxoid, Poliovirus type mahoney, Poliovirus type mef1, Poliovirus type saukett, Tetanus toxoid | Kanada | Im Handel | 2011 |
| Adacel Polio, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv difterije, tetanusa, hripavca (nestanično, komponentno) i poliomijelitisa (inaktivirano) sa smanjenim sadržajem antigena, adsorbirano*suspenzija za injekciju u napunjenoj štrcaljki | Toksoid difterije, Tetanus toxoid, Toksoid hripavca, Filamentozni hemaglutinin hripavca, Pertaktin hripavca, Fimbrijalni aglutinogeni hripavca i, Poliovirus tip soj mahoney, Poliovirus tip soj mef-1, Poliovirus tip soj saukett | Kroatien | Nicht im Handel | 2024 |
| ADACEL®-POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE5 µg/ 0.5 ml + 5 µg/0.5 ml + 3 µg/0.5 ml + 2.5 µg/ 0.5 ml + 2Lf + 40 D-Antigen Units + 8 D-antigen units + 32 D-antigen units + 5Lf · Injection, suspension | Filamentous haemagglutinin adsorbed, Fimbriae type and adsorbed, Pertactin adsorbed, Pertussis toxoid adsorbed, Diphtheria toxoid adsorbed, Inactivated poliomyelitis vaccine type mahoney, Inactivated poliomyelitis vaccine type, Tetanus toxoid | Singapur | Zugelassen | 2018 |
| Adacel®, Suspension for Injection5 micrograms + 5 micrograms + 3 micrograms + 2.5 micrograms + 2 Lf + 5 Lf · Injection, suspension | Filamentous haemagglutinin adsorbed, Fimbriae type and adsorbed, Pertactin adsorbed, Pertussis toxoid adsorbed, Diphtheria toxoid adsorbed, Tetanus toxoid | Singapur | Zugelassen | 2012 |
| ADACEL, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML5 μg/ 0.5mL + 5 μg/ 0.5mL + 3 μg/ 0.5mL + 2.5 μg/ 0.5mL + 2 LF/ 0.5mL + 5 LF/ 0.5mL · Injection, suspension | Filamentoushaemagglutinin adsorbed, Fimbriae type and, Pertactin adsorbed, Pertussis toxoidadsorbed, Diphtheria toxoid adsorbed, Tetanus toxoid | Singapur | Zugelassen | 2026 |
Wo es Zulassungen hält oder Arzneimittel herstellt, und wie viele davon aktuell sind.
| Land | Arzneimittel | Aktuell | Früher | Unternehmen |
|---|---|---|---|---|
| Brasilien | 1.033 | 192 | 841 | UnternehmenAlle Arzneimittel |
| Kanada | 544 | 136 | 408 | UnternehmenAlle Arzneimittel |
| Spanien | 319 | 278 | 41 | UnternehmenAlle Arzneimittel |
| Saudi-Arabien | 251 | 251 | 0 | UnternehmenAlle Arzneimittel |
| Vereinigte Staaten | 206 | 191 | 15 | UnternehmenAlle Arzneimittel |
| Niederlande | 183 | 183 | 0 | UnternehmenAlle Arzneimittel |
| Rumänien | 158 | 0 | 158 | UnternehmenAlle Arzneimittel |
| Singapur | 87 | 87 | 0 | UnternehmenAlle Arzneimittel |
| Europäische Union (EMA) | 76 | 52 | 24 | UnternehmenAlle Arzneimittel |
| Kolumbien | 71 | 0 | 71 | UnternehmenAlle Arzneimittel |
| Kroatien | 35 | 35 | 0 | UnternehmenAlle Arzneimittel |
| Argentinien | 1 | 0 | 1 | UnternehmenAlle Arzneimittel |
| Italien | 1 | 1 | 0 | UnternehmenAlle Arzneimittel |
Auch registriert in: Frankreich, Malaysia, Schweden, Serbien, Vereinigtes Königreich
Die ATC-Gruppen, zu denen die meisten seiner Arzneimittel gehören, größte zuerst.
Die Wirkstoffe in den meisten seiner Arzneimittel.
Wie die Register den Namen schreiben, normalisiert: ohne Rechtsform, Akzente und Großbuchstaben.
Von Prognia aus den unten genannten öffentlichen Arzneimittel- und Unternehmensregistern zusammengestellt. Logos werden nicht verwendet.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Source: European Medicines Agency (EPAR data).
Lizenz: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Lizenz: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Lizenz: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Lizenz: Licence Ouverte v1.0
Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - julio 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.
Lizenz: Creative Commons Attribution
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Lizenz: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Lizenz: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Lizenz: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM renovacion; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos, dataset vwwf-4ftk, rowsUpdatedAt 1792152641, acquired 2026-10-26; original values retained.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Lizenz: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Lizenz: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; Crown copyright MHRA factual register
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Lizenz: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Lizenz: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Lizenz: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci-con-dettaglio-autorizzazioni/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:44.771040+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Lizenz: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Lizenz: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Lizenz: Italian Open Data Licence
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Lizenz: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Lizenz: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Lizenz: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Lizenz: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Lizenz: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Lizenz: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Lizenz: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Fehler melden oder Entfernung beantragenKorrekturen vom Unternehmen selbst sind willkommen.
Halten Sie die Arzneimittel von Sanofi auf Prognia korrekt, sehen Sie, wie Fachleute sie nutzen, und beantworten Sie ihre Fragen. Ein 20-minütiges Gespräch, auf Englisch.
Gespräch buchenBekannte Pharmakonzerne, jeweils mit allen Unternehmen.
Nach der Zahl ihrer Arzneimittel geordnet.